AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure

... the combination treatment AZOR(R) (amlodipine and olmesartan medoxomil) as initial or 'first-line' therapy in p...pressure goals with AZOR compared to amlodipine or olmesartan medoxomil alone. About AZOR AZOR is a co...rance of calcium into the blood vessel walls, with olmesartan medoxomil, the active ingredient in Benicar(R), wh...

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings

...ar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension. *Azor is...

FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension

...ar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension. *Azor is...

Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize

...ew anti- hypertensive drug, AZORTM (amlodipine and olmesartan medoxomil), a fixed-dose combination of the calciu...odipine and the angiotensin receptor blocker (ARB) olmesartan medoxomil, or BENICAR(R). In the next several mont...d calcium channel blocker (CCB) on the market, and olmesartan medoxomil. The combination of these two medication...

AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure

...es Food and Drug Administration (FDA) has approved AZOR(TM) (amlodipine and olmesartan medoxomil) for the treatment of hypertension, also known as high blood pres.../or salt-depleted patients, symptomatic hypotension due particularly to the olmesartan component may occur after initiation of treatment with AZOR. Treatment shou...

Olmesartan in Medical Technology

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

AZTEC Trial First to Examine AZOR Using 24-Hour Ambulatory BP Measures PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that data presented at the American Society of Hypertension, Inc. (ASH) Twenty-Fourth Annual Scientific Meeting and Exposition (ASH 2009) in San ...

Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

First Release of Data for New Combination PARSIPPANY, N.J., May 21, 2007 /PRNewswire/ -- Combining the calcium channel blocker amlodipine besylate with the angiotensin receptor blocker olmesartan medoxomil, produced significant mean reductions in seated systolic and diastolic blood pressure in pat...

Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

First Release of Data for New Combination PARSIPPANY, NJ (May 21, 2007) -- Combining the calcium channel blocker amlodipine besylate with the angiotensin receptor blocker olmesartan medoxomil, produced significant mean reductions in seated systolic and diastolic blood pressure in pat...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... First-Ever Trial to Evaluate Whether olmesartan Medoxomil Prevents Onset of Early Kidney Disease i... whether the angiotensin II receptor blocker (ARB) olmesartan medoxomil can prevent the onset of microalbuminuri...tion, which includes patients randomized either to olmesartan or placebo in addition to standard antihypertensiv...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... BP-lowering efficacy of the proposed titration of olmesartan medoxomil and olmesartan medoxomil/hydrochlorothiazide in 178 patients age ...ng a 2-3 week placebo period, 176 patients started olmesartan (OM) 20 mg. If SBP remained greater than or equal ...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

...nsion demonstrates that the hypertension treatment olmesartan medoxomil was effective in reversing the narrowing... The study, titled VIOS (Vascular Improvement with olmesartan medoxomil Study) was a one-year, exploratory study...g effects of these agents.(1) In the VIOS trial, olmesartan medoxomil, through early blockade of angiotensin I...

Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations

...powerful combination drug AZOR(TM) (amlodipine and olmesartan medoxomil) safely and effectively helped patients ...) to determine if amlodipine (AML) 5-10mg/day plus olmesartan (OM) 10-40 mg/day for eight weeks is more efficaci...s, symptomatic hypotension due particularly to the olmesartan component may occur after initiation of treatment ...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

...Patients who met inclusion criteria (n=276) were then randomized to receive olmesartan (OM) or placebo according to a titration scheme consisting of a 12-week double-blind study period. Patients randomized to olmesartan initially received 20 mg/day. If BP remained greater than or equal to 120/8...

Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression

...ar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension. *Azor is...

Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show

...ar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension. *Azor is ...

Olmesartan in Biological News

Hypertension treatment effective in reversing vascular damage

...STON-SALEM, N.C. A hypertension medication called olmesartan medoxomil is effective in reversing the narrowing ...e one-year study, titled Vascular Improvement with olmesartan medoxomil Study (VIOS), was published in the curre...structure in patients with stage 1 hypertension. olmesartan medoxomil is marketed in the United States as Beni...

Olmesartan in Biological Technology

DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin

MUNICH, Germany, October 1 /PRNewswire/ -- - New Product Under Development for the Treatment of High Blood Pressure - Approval Requested in 28 European Countries DAIICHI SANKYO EUROPE GmbH has applied in 28 European countries for approval of a new antihypertensive medication. It is a fixed ...

CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group

...ncluding atorvastatin (Lipitor(R)), sitagliptin (Januvia(R)), esomeprazole (Nexium(R)), fluticasone/salmeterol (Advair(R)), nebivolol (Nebilet(R)) and olmesartan (Benicar(R)). "Ranexa represents an important first in class product which we believe will help meet the substantial unmet needs of patients across ...

Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement

... have terminated their co-promotion agreement for AZOR(TM)* (amlodipine and olmesartan medoxomil), Daiichi Sankyo's fixed-dose combination of two antihypertensive...um channel blocker amlodipine besylate and the angiotensin receptor blocker olmesartan medoxomil. Forest will record a one-time charge of $44.1 million which is c...

Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension

...ar HCT(R)* (olmesartan medoxomil-hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, and AZOR(TM)* (amlodipine and olmesartan medoxomil) a calcium channel blocker and angiotensin receptor blocker combination product, all indicated for the treatment of hypertension. *Azor is...